GE Healthcare acquires bioprocessing start-up Puridify in 2017
GE Healthcare completed an acquisition of Puridify in 2017, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing, promising faster mass transfer, scalability and ease of use.
The company raised $4.9m over 3 rounds after having presented to Enterprise 100 members for its seed round in 2014.
See source article
